News Results
There are 778,229 News Results
Jun 18, 2019
DUBLIN, June 18, 2019 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today reported new data from the Company's Phase 2 clinical trial of ampreloxetine (TD-9855)...
Jun 24, 2019
NEW YORK, June 24, 2019 /PRNewswire/ --
Jul 3, 2019
NEW YORK, July 03, 2019 /PRNewswire-PRWeb/ -- Research shows that every $1 that businesses invest in user experience design can cultivate a return on investment of up to $100 or...
Jul 10, 2019
-- Diginex is a blockchain financial services and technology company. The proposed transaction with 8i described below will result in Diginex being listed on Nasdaq -- Diginex is well positioned...
Jul 22, 2019
DUBLIN, July 22, 2019 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today reported new data from the Company's Phase 2 clinical trial of ampreloxetine (TD-9855)...
Jul 25, 2019
NEW YORK, July 25, 2019 /PRNewswire/ -- Standard Motor Products, Inc. (NYSE: SMP), an automotive replacement parts manufacturer and distributor, reported today its consolidated financial results for the three months...
Aug 8, 2019
HOUSTON, Aug. 8, 2019 /PRNewswire/ -- Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and...
Aug 16, 2019
Central Puerto S.A (“Central Puerto” or the “Company”) (NYSE: CEPU), the largest private sector power generation company in Argentina, as measured by generated power, reports complementary information for the quarter...
Aug 27, 2019
DALLAS and BOONTON, N.J., Aug. 27, 2019 /PRNewswire/ -- SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, and Enteris BioPharma, Inc. ("Enteris"), a...
Sep 9, 2019
HOD HASHARON, Israel, Sept. 9, 2019 /PRNewswire/ -- Wize Pharma , Inc. (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced it has entered...
